News
06-07-2010, 05:30 AM
Geron Corporation today announced the presentation of data from the clinical trial of imetelstat (GRN163L), the company's telomerase inhibitor drug, in combination with paclitaxel and bevacizumab in patients with breast cancer at the 2010 American Society of Clinical Oncology annual meeting in Chicago.
More... (http://www.news-medical.net/news/20100607/Clinical-trial-data-of-imetelstat-in-patients-with-breast-cancer-presented-at-ASCO-annual-meeting.aspx)
More... (http://www.news-medical.net/news/20100607/Clinical-trial-data-of-imetelstat-in-patients-with-breast-cancer-presented-at-ASCO-annual-meeting.aspx)